首页 > 最新文献

Digestive Surgery最新文献

英文 中文
Endoscopic Negative Pressure Therapy for Post-Sleeve Gastrectomy Proximal Staple-Line Leaks: A Single-Center Experience of 40 Patients. 内镜负压治疗胃套管切除术后近端钉线泄漏:40例患者的单中心经验。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-03-11 DOI: 10.1159/000545177
Vasiliki Christogianni, Matthias Ross, Radostina Dukovska, Ashwini Rao, Martin Buesing, Markus Reiser

Introduction: Post-sleeve gastrectomy (SG) proximal staple-line leak is a rare yet serious complication. Endoscopic negative pressure therapy (ENPT) has emerged as a safe technique, showing promising results in treating anastomotic leakages in the upper and lower gastrointestinal tract, often in conjunction with surgical interventions. A standardized treatment algorithm has not been established. This study aimed to assess the safety and efficacy of ENPT in the multidisciplinary management of proximal staple-line leaks after SG.

Methods: This is an observational study of 40 post-SG proximal staple-line leak cases treated with an ENPT-based approach. Revisional surgery was performed in addition to ENPT in critically ill patients or nondiagnostic imaging results. Success was defined as the healing of the defect and paraluminal cavity with no further need for surgical or endoscopic intervention following ENPT.

Results: Thirty-three patients were successfully treated with ENPT (82.5% success rate). Additional surgical interventions were performed in 37 patients, with re-laparoscopy, lavage, and drain of the abdominal cavity being the most frequently performed procedures. The mean duration of treatment was 25.6 days, with an average of 6.4 endoscopic interventions per patient.

Conclusions: ENPT is a safe and effective technique for treating proximal staple-line leaks following SG. Its application should be considered alongside other endoscopic and surgical approaches.

简介:袖后胃切除术(SG)近端钉线漏是一种罕见但严重的并发症。内窥镜负压疗法(ENPT)已成为一种安全的技术,在治疗上消化道和下消化道渗漏方面显示出良好的效果,通常与手术干预相结合。标准化的治疗算法尚未建立。本研究旨在评估ENPT在SG术后近端钉线渗漏多学科治疗中的安全性和有效性。方法:这是一项观察性研究,采用基于enpt的方法治疗40例sg后近端钉线泄漏病例。除ENPT外,对危重患者或非诊断性影像学结果进行修正手术。成功的定义是缺损和腔旁腔的愈合,在ENPT后不再需要手术或内窥镜干预。结果:ENPT治疗成功33例,成功率82.5%。37例患者接受了额外的手术干预,其中再腹腔镜检查、灌洗和腹腔引流是最常见的手术。平均治疗时间为25.6天,平均每位患者进行6.4次内镜干预。结论:ENPT是治疗SG术后近端钉线渗漏安全有效的技术。其应用应考虑与其他内窥镜和手术途径。
{"title":"Endoscopic Negative Pressure Therapy for Post-Sleeve Gastrectomy Proximal Staple-Line Leaks: A Single-Center Experience of 40 Patients.","authors":"Vasiliki Christogianni, Matthias Ross, Radostina Dukovska, Ashwini Rao, Martin Buesing, Markus Reiser","doi":"10.1159/000545177","DOIUrl":"10.1159/000545177","url":null,"abstract":"<p><strong>Introduction: </strong>Post-sleeve gastrectomy (SG) proximal staple-line leak is a rare yet serious complication. Endoscopic negative pressure therapy (ENPT) has emerged as a safe technique, showing promising results in treating anastomotic leakages in the upper and lower gastrointestinal tract, often in conjunction with surgical interventions. A standardized treatment algorithm has not been established. This study aimed to assess the safety and efficacy of ENPT in the multidisciplinary management of proximal staple-line leaks after SG.</p><p><strong>Methods: </strong>This is an observational study of 40 post-SG proximal staple-line leak cases treated with an ENPT-based approach. Revisional surgery was performed in addition to ENPT in critically ill patients or nondiagnostic imaging results. Success was defined as the healing of the defect and paraluminal cavity with no further need for surgical or endoscopic intervention following ENPT.</p><p><strong>Results: </strong>Thirty-three patients were successfully treated with ENPT (82.5% success rate). Additional surgical interventions were performed in 37 patients, with re-laparoscopy, lavage, and drain of the abdominal cavity being the most frequently performed procedures. The mean duration of treatment was 25.6 days, with an average of 6.4 endoscopic interventions per patient.</p><p><strong>Conclusions: </strong>ENPT is a safe and effective technique for treating proximal staple-line leaks following SG. Its application should be considered alongside other endoscopic and surgical approaches.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"97-104"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143604284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q). 不可逆电穿孔治疗结直肠肝转移的当前实践:一项国际问卷调查(LIVERMET-IRE-Q)。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-16 DOI: 10.1159/000543634
Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, Nicola De Liguori Carino, Panagiotis Stathakis, Vinotha Nadarajah, Krishna V Menon, Sanjay Pandanaboyana, Adam E Frampton, Tze Min Wah, Shahid Farid, Hassan Z Malik, Robert P Jones, Jonathan Evans, Ajith K Siriwardena

Introduction: Irreversible electroporation (IRE) is a form of non-thermal ablation that delivers pulses of high-voltage electric current between electrodes. Although IRE has been demonstrated to achieve tumor necrosis, its role in the treatment of colorectal hepatic metastases is unestablished. This study is an international questionnaire survey on the use of IRE for patients with colorectal hepatic metastases.

Methods: A questionnaire addressing views on the use of IRE for colorectal liver metastases was circulated to clinicians with an interest and/or expertise in this technique. The questionnaire addressed indications for the use of IRE in a range of scenarios: methods of use, assessment of treatment response, and outcome.

Results: 64 clinicians from 17 different countries replied to the questionnaire. The preferred mode of delivery of IRE was percutaneous treatment under computed tomographic guidance. Thirty-three (70% of 47 respondents) used IRE exclusively for lesions in proximity to inflow or outflow structures. Twenty (43% respondents) used IRE as their sole ablative treatment, while 19 (40% of 47 respondents) used IRE in combination with thermal ablation. The maximum number of lesions that could be treated by IRE was two and the preferred size of lesion was <3 cm.

Conclusion: Respondents to this international questionnaire survey indicate that IRE is an acceptable ablative option for small colorectal liver metastases (<3 m in diameter) close to inflow/outflow structures.

简介:不可逆电穿孔(IRE)是一种非热烧蚀的形式,在电极之间传递高压电流脉冲。尽管IRE已被证明可实现肿瘤坏死,但其在治疗结直肠癌肝转移中的作用尚未确定。本研究是一项关于IRE在结直肠癌肝转移患者中的应用的国际问卷调查。方法:一份关于IRE用于结直肠肝转移的调查问卷被分发给对该技术感兴趣和/或专业知识的临床医生。该问卷调查了在一系列情况下使用IRE的适应症、使用方法、治疗反应和结果的评估。结果:来自17个不同国家的64名临床医生回答了问卷。IRE的首选传递方式是在CT引导下经皮治疗。33人(47名应答者中的70%)仅对靠近流入或流出结构的病变使用IRE。20人(43%)使用IRE作为唯一的消融治疗,而19人(47人中的40%)使用IRE联合热消融治疗。结论:本次国际问卷调查的受访者认为,对于靠近流入/流出结构的小结直肠肝转移瘤(直径< 3 m), IRE是一种可接受的消融选择。
{"title":"Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q).","authors":"Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, Nicola De Liguori Carino, Panagiotis Stathakis, Vinotha Nadarajah, Krishna V Menon, Sanjay Pandanaboyana, Adam E Frampton, Tze Min Wah, Shahid Farid, Hassan Z Malik, Robert P Jones, Jonathan Evans, Ajith K Siriwardena","doi":"10.1159/000543634","DOIUrl":"10.1159/000543634","url":null,"abstract":"<p><strong>Introduction: </strong>Irreversible electroporation (IRE) is a form of non-thermal ablation that delivers pulses of high-voltage electric current between electrodes. Although IRE has been demonstrated to achieve tumor necrosis, its role in the treatment of colorectal hepatic metastases is unestablished. This study is an international questionnaire survey on the use of IRE for patients with colorectal hepatic metastases.</p><p><strong>Methods: </strong>A questionnaire addressing views on the use of IRE for colorectal liver metastases was circulated to clinicians with an interest and/or expertise in this technique. The questionnaire addressed indications for the use of IRE in a range of scenarios: methods of use, assessment of treatment response, and outcome.</p><p><strong>Results: </strong>64 clinicians from 17 different countries replied to the questionnaire. The preferred mode of delivery of IRE was percutaneous treatment under computed tomographic guidance. Thirty-three (70% of 47 respondents) used IRE exclusively for lesions in proximity to inflow or outflow structures. Twenty (43% respondents) used IRE as their sole ablative treatment, while 19 (40% of 47 respondents) used IRE in combination with thermal ablation. The maximum number of lesions that could be treated by IRE was two and the preferred size of lesion was <3 cm.</p><p><strong>Conclusion: </strong>Respondents to this international questionnaire survey indicate that IRE is an acceptable ablative option for small colorectal liver metastases (<3 m in diameter) close to inflow/outflow structures.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"116-126"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of Risk Factors Associated with Incidental Appendiceal Neoplasms in Patients with Acute Appendicitis. 急性阑尾炎患者偶发阑尾肿瘤相关危险因素回顾性分析。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-07-29 DOI: 10.1159/000547699
Susumu Doita, Fumitaka Taniguchi, Kengo Mouri, Eiki Miyake, Toshihiro Ogawa, Megumi Watanabe, Takashi Arata, Kou Katsuda, Kohji Tanakaya, Hideki Aoki

Introduction: As the nonoperative management of acute appendicitis becomes more widespread, identifying patients at high risk of appendiceal tumors is increasingly important. This study aimed to clarify the predictive factors of appendiceal tumors before appendectomy.

Methods: We retrospectively analyzed 434 patients diagnosed with acute appendicitis who underwent emergency or interval appendectomy.

Results: Appendiceal neoplasms were found in 3.9% of patients. Patients with tumors were significantly older (64.4 vs. 49.6 years, p < 0.001). The tumor group exhibited a lower appendicolith incidence (48% vs. 12%, p = 0.011) and larger appendiceal diameters (18.0 vs. 12.3 mm, p < 0.001). Multivariate analysis demonstrated that age ≥60 years, absence of appendicolith, and an appendiceal diameter ≥12 mm were independent risk factors of appendiceal tumors. Among patients who underwent interval appendectomy, only the non-tumor group exhibited significant improvement in appendiceal diameter after nonoperative management (tumor, +1.6 mm vs. no tumor, -3.5 mm, p < 0.001).

Conclusions: Advanced age, absence of appendicolith, and an enlarged appendiceal diameter may be significant predictive factors of appendiceal tumors. These factors will aid in the selection of appropriate appendicitis treatment strategies.

目的随着急性阑尾炎的非手术治疗越来越普遍,识别阑尾肿瘤的高危患者变得越来越重要。本研究旨在阐明阑尾切除术前阑尾肿瘤的预测因素。方法回顾性分析434例急性阑尾炎患者行急诊或间歇阑尾切除术。结果阑尾肿瘤发生率为3.9%。肿瘤患者年龄明显增大(64.4岁vs 49.6岁,p
{"title":"Retrospective Analysis of Risk Factors Associated with Incidental Appendiceal Neoplasms in Patients with Acute Appendicitis.","authors":"Susumu Doita, Fumitaka Taniguchi, Kengo Mouri, Eiki Miyake, Toshihiro Ogawa, Megumi Watanabe, Takashi Arata, Kou Katsuda, Kohji Tanakaya, Hideki Aoki","doi":"10.1159/000547699","DOIUrl":"10.1159/000547699","url":null,"abstract":"<p><strong>Introduction: </strong>As the nonoperative management of acute appendicitis becomes more widespread, identifying patients at high risk of appendiceal tumors is increasingly important. This study aimed to clarify the predictive factors of appendiceal tumors before appendectomy.</p><p><strong>Methods: </strong>We retrospectively analyzed 434 patients diagnosed with acute appendicitis who underwent emergency or interval appendectomy.</p><p><strong>Results: </strong>Appendiceal neoplasms were found in 3.9% of patients. Patients with tumors were significantly older (64.4 vs. 49.6 years, p < 0.001). The tumor group exhibited a lower appendicolith incidence (48% vs. 12%, p = 0.011) and larger appendiceal diameters (18.0 vs. 12.3 mm, p < 0.001). Multivariate analysis demonstrated that age ≥60 years, absence of appendicolith, and an appendiceal diameter ≥12 mm were independent risk factors of appendiceal tumors. Among patients who underwent interval appendectomy, only the non-tumor group exhibited significant improvement in appendiceal diameter after nonoperative management (tumor, +1.6 mm vs. no tumor, -3.5 mm, p < 0.001).</p><p><strong>Conclusions: </strong>Advanced age, absence of appendicolith, and an enlarged appendiceal diameter may be significant predictive factors of appendiceal tumors. These factors will aid in the selection of appropriate appendicitis treatment strategies.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"213-219"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Robotic Surgery on Postoperative Pancreatic Fistula for High-Risk Pancreaticojejunostomy after Pancreatoduodenectomy. 机器人手术对胰十二指肠切除术后高危胰空肠吻合术胰瘘的影响。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-24 DOI: 10.1159/000543737
Tomokazu Fuji, Kosei Takagi, Yuzo Umeda, Kazuya Yasui, Motohiko Yamada, Yasuo Nagai, Toshiyoshi Fujiwara

Introduction: The safety and feasibility of robotic pancreatoduodenectomy (RPD) in high-risk patients for postoperative pancreatic fistula (POPF) have rarely been investigated, although the rate of POPF is lower than in open pancreatoduodenectomy (OPD). This study aimed to examine the impact of robotic surgery on POPF in high-risk patients after pancreatoduodenectomy (PD).

Methods: We performed a retrospective study of 204 patients who underwent RPD and OPD between January 2018 and June 2023. Of the 204 patients, 126 with high-risk pancreaticojejunostomies for developing POPF were included. The outcomes of RPD and OPD were compared. Multivariate analyses were conducted to identify risk factors associated with the development of clinically relevant POPF (CR-POPF) after surgery.

Results: Of the 126 patients, 50 underwent RPD and 76 underwent OPD. The incidence of CR-POPF was significantly lower in the RPD group than in the OPD group (6.0% vs. 38.2%, p < 0.001). Multivariate analyses identified OPD as an independent risk factor associated with CR-POPF (odds ratio [OR]: 7.87, 95% confidence interval [CI]: 2.11-29.4, p = 0.002).

Conclusion: This study demonstrated the impact of robotic surgery on POPF in high-risk patients after PD. These results suggest that RPD may be significantly associated with a decreased incidence of CR-POPF in high-risk anastomoses.

背景:机器人胰十二指肠切除术(RPD)在术后胰瘘(POPF)高危患者中的安全性和可行性很少被研究,尽管POPF的发生率低于开放式胰十二指肠切除术(OPD)。本研究旨在探讨机器人手术对胰十二指肠切除术(PD)后高风险患者胰瘘的影响:这项回顾性分析纳入了 2018 年 1 月至 2023 年 6 月间接受 RPD 的 204 例患者。在这 204 名患者中,纳入了 126 名高风险 POPF 患者。比较了 RPD 和 OPD 的结果。进行了多变量分析,以确定术后发生临床相关 POPF(CR-POPF)的相关风险因素:在126名患者中,50人接受了RPD手术,76人接受了OPD手术。RPD组的CR-POPF发生率明显低于OPD组(6.0% vs. 38.2%,P < 0.001)。多变量分析发现,OPD 是与 CR-POPF 相关的独立风险因素(几率比 [OR]:7.87,95% 置信区间 [CI]:2.11-29.4,P = 0.002):本研究证明了机器人手术对PD术后高危患者POPF的影响。这些结果表明,在高风险吻合口中,RPD 可能与 CR-POPF 发生率的降低显著相关。
{"title":"Impact of Robotic Surgery on Postoperative Pancreatic Fistula for High-Risk Pancreaticojejunostomy after Pancreatoduodenectomy.","authors":"Tomokazu Fuji, Kosei Takagi, Yuzo Umeda, Kazuya Yasui, Motohiko Yamada, Yasuo Nagai, Toshiyoshi Fujiwara","doi":"10.1159/000543737","DOIUrl":"10.1159/000543737","url":null,"abstract":"<p><strong>Introduction: </strong>The safety and feasibility of robotic pancreatoduodenectomy (RPD) in high-risk patients for postoperative pancreatic fistula (POPF) have rarely been investigated, although the rate of POPF is lower than in open pancreatoduodenectomy (OPD). This study aimed to examine the impact of robotic surgery on POPF in high-risk patients after pancreatoduodenectomy (PD).</p><p><strong>Methods: </strong>We performed a retrospective study of 204 patients who underwent RPD and OPD between January 2018 and June 2023. Of the 204 patients, 126 with high-risk pancreaticojejunostomies for developing POPF were included. The outcomes of RPD and OPD were compared. Multivariate analyses were conducted to identify risk factors associated with the development of clinically relevant POPF (CR-POPF) after surgery.</p><p><strong>Results: </strong>Of the 126 patients, 50 underwent RPD and 76 underwent OPD. The incidence of CR-POPF was significantly lower in the RPD group than in the OPD group (6.0% vs. 38.2%, p < 0.001). Multivariate analyses identified OPD as an independent risk factor associated with CR-POPF (odds ratio [OR]: 7.87, 95% confidence interval [CI]: 2.11-29.4, p = 0.002).</p><p><strong>Conclusion: </strong>This study demonstrated the impact of robotic surgery on POPF in high-risk patients after PD. These results suggest that RPD may be significantly associated with a decreased incidence of CR-POPF in high-risk anastomoses.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"49-58"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143045822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of Risk Factors and an Identification Signature for Bacteremia in Acute Cholecystitis. 探讨急性胆囊炎菌血症的危险因素和识别特征。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-03-07 DOI: 10.1159/000545140
Satoshi Nishiwada, Tetsuya Tanaka, Kenji Uno, Yuki Kirihataya, Takeshi Takei, Tomomi Sadamitsu, Akihiro Kajita, Mayuko Kikuchi, Yoshiki Tamada, Masaru Enoki, Kazusuke Matsumoto, Junya Suzuki, Hazuki Horiuchi, Yasushi Okura, Teruyuki Hidaka, Masayoshi Sawai, Atsushi Yoshimura

Introduction: Acute cholecystitis (AC) is one of the most common abdominal emergencies worldwide. Biliary infections can easily induce bacteremia, leading to severe general conditions including systemic inflammation and blood coagulation abnormalities. However, bacteremia in AC has not been investigated so far. Herein, we analyzed the blood cultures and clinical data of patients with AC to identify the risk factors and develop a statistical identification model for bacteremia.

Methods: Of 319 consecutive patients with AC at our hospital, we retrospectively investigated 176 patients who were evaluated by blood culture at diagnosis to assess risk factors and develop an identification model for bacteremia in AC.

Results: Based on blood culture results, 37 (21.0%) of 176 patients were diagnosed with bacteremia. The bacteremia-positive group had a significantly worse systemic status at diagnosis than the negative group, including age, severity grading, comorbidities, performance status, systemic inflammatory status, and blood coagulation abnormalities. Multivariate analysis revealed previous endoscopic papillary procedures, total bilirubin, and systemic inflammatory response syndrome ≥3 as significant risk factors for bacteremia. On dividing early and late cohorts according to the onset time of AC, an identification signature derived from the three risk factors robustly distinguished bacteremia in both cohorts (area under the curve, early cohort = 0.93; late cohort = 0.91).

Conclusions: In this study, we identified risk factors and signatures that accurately detect bacteremia in patients with AC. This study enriches our medical knowledge of AC, helping us step toward designing individualized treatment strategies for this disease.

背景:急性胆囊炎是世界范围内最常见的腹部急症之一。胆道感染容易引起菌血症,导致全身炎症和凝血异常等严重的一般情况。然而,迄今为止尚未对AC中的菌血症进行研究。方法:对我院连续319例AC患者进行回顾性调查,对诊断时进行血培养评价的176例AC患者进行回顾性调查,探讨AC菌血症的危险因素,建立AC菌血症的鉴别模型。结果:根据血培养结果,176例患者中37例(21.0%)确诊为菌血症。细菌阳性组在诊断时的全身状况明显差于阴性组,包括年龄、严重程度分级、合并症、运动状态、全身炎症状态和凝血异常。多因素分析显示,既往内镜乳头状手术、总胆红素和系统性炎症反应综合征≥3是菌血症的重要危险因素。根据AC发病时间划分早期和晚期队列,由三个危险因素得出的识别特征强有力地区分了两个队列中的菌血症(AUC,早期队列= 0.93;晚期队列= 0.91)。结论:在本研究中,我们确定了准确检测AC患者菌血症的危险因素和识别特征。本研究丰富了我们对AC的医学知识,有助于我们设计针对该疾病的个性化治疗策略。
{"title":"Exploration of Risk Factors and an Identification Signature for Bacteremia in Acute Cholecystitis.","authors":"Satoshi Nishiwada, Tetsuya Tanaka, Kenji Uno, Yuki Kirihataya, Takeshi Takei, Tomomi Sadamitsu, Akihiro Kajita, Mayuko Kikuchi, Yoshiki Tamada, Masaru Enoki, Kazusuke Matsumoto, Junya Suzuki, Hazuki Horiuchi, Yasushi Okura, Teruyuki Hidaka, Masayoshi Sawai, Atsushi Yoshimura","doi":"10.1159/000545140","DOIUrl":"10.1159/000545140","url":null,"abstract":"<p><strong>Introduction: </strong>Acute cholecystitis (AC) is one of the most common abdominal emergencies worldwide. Biliary infections can easily induce bacteremia, leading to severe general conditions including systemic inflammation and blood coagulation abnormalities. However, bacteremia in AC has not been investigated so far. Herein, we analyzed the blood cultures and clinical data of patients with AC to identify the risk factors and develop a statistical identification model for bacteremia.</p><p><strong>Methods: </strong>Of 319 consecutive patients with AC at our hospital, we retrospectively investigated 176 patients who were evaluated by blood culture at diagnosis to assess risk factors and develop an identification model for bacteremia in AC.</p><p><strong>Results: </strong>Based on blood culture results, 37 (21.0%) of 176 patients were diagnosed with bacteremia. The bacteremia-positive group had a significantly worse systemic status at diagnosis than the negative group, including age, severity grading, comorbidities, performance status, systemic inflammatory status, and blood coagulation abnormalities. Multivariate analysis revealed previous endoscopic papillary procedures, total bilirubin, and systemic inflammatory response syndrome ≥3 as significant risk factors for bacteremia. On dividing early and late cohorts according to the onset time of AC, an identification signature derived from the three risk factors robustly distinguished bacteremia in both cohorts (area under the curve, early cohort = 0.93; late cohort = 0.91).</p><p><strong>Conclusions: </strong>In this study, we identified risk factors and signatures that accurately detect bacteremia in patients with AC. This study enriches our medical knowledge of AC, helping us step toward designing individualized treatment strategies for this disease.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"84-96"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143585131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total Pancreatectomy with "Superior Mesenteric Artery-First Approach". “SMA-First入路”全胰切除术。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-10 DOI: 10.1159/000546363
Kosei Takagi, Tomokazu Fuji, Kazuya Yasui, Motohiko Yamada, Takeyoshi Nishiyama, Yasuo Nagai, Noriyuki Kanehira, Toshiyoshi Fujiwara, Kosei Takagi

Introduction: Total pancreatectomy (TP) is a technically demanding procedure for patients with multifocal pancreatic diseases. Although the benefits of the superior mesenteric artery (SMA)-first approach for pancreatic cancer (PC) have been reported in pancreatic surgery, few studies have demonstrated surgical techniques of SMA-first approach in TP.

Methods: This report presents our novel SMA-first approach for PC in TP, including six steps. First, the resectability was confirmed (step 1). Next, SMA approach was applied (step 2). In this step, the anterior and left sides of the SMA were dissected, and the left renal vein was confirmed. Following retroperitoneal dissection (step 3), the pancreatic body and tail were completely mobilized (step 4). Subsequently, Whipple procedure was performed with lymphadenectomy around the right side of the SMA (step 5). Finally, hepaticojejunostomy and gastrojejunostomy were performed (step 6). Using SMA-first approach, en bloc resection with adequate lymphadenectomy around the SMA and retroperitoneal dissection was performed.

Conclusion: The present study presents surgical techniques of TP using the SMA-first approach for PC. This unique approach may be useful to perform TP for PC to obtain negative resection margins.

简介:对于多灶性胰腺疾病患者,全胰腺切除术(TP)是一项技术要求很高的手术。虽然在胰腺手术中已经报道了肠系膜上动脉(SMA)优先入路治疗胰腺癌(PC)的益处,但很少有研究证明SMA优先入路治疗TP的手术技术。方法:本报告介绍了我们新颖的SMA-first方法,包括六个步骤。首先,确认可切除性(步骤1)。接下来,应用SMA方法(步骤2)。在这一步中,切开SMA的前部和左侧,并确认左肾静脉。腹膜后剥离(步骤3)后,胰体和胰尾完全活动(步骤4)。随后,行Whipple手术,在SMA右侧周围行淋巴结切除术(步骤5)。最后行肝空肠吻合术和胃空肠吻合术(第6步)。采用SMA-first入路,进行SMA周围充分淋巴结切除和腹膜后清扫的整体切除。结论:本研究提出了采用SMA-first入路治疗前列腺癌的手术技术。这种独特的方法可能有助于为PC执行TP以获得负切除边缘。
{"title":"Total Pancreatectomy with \"Superior Mesenteric Artery-First Approach\".","authors":"Kosei Takagi, Tomokazu Fuji, Kazuya Yasui, Motohiko Yamada, Takeyoshi Nishiyama, Yasuo Nagai, Noriyuki Kanehira, Toshiyoshi Fujiwara, Kosei Takagi","doi":"10.1159/000546363","DOIUrl":"10.1159/000546363","url":null,"abstract":"<p><strong>Introduction: </strong>Total pancreatectomy (TP) is a technically demanding procedure for patients with multifocal pancreatic diseases. Although the benefits of the superior mesenteric artery (SMA)-first approach for pancreatic cancer (PC) have been reported in pancreatic surgery, few studies have demonstrated surgical techniques of SMA-first approach in TP.</p><p><strong>Methods: </strong>This report presents our novel SMA-first approach for PC in TP, including six steps. First, the resectability was confirmed (step 1). Next, SMA approach was applied (step 2). In this step, the anterior and left sides of the SMA were dissected, and the left renal vein was confirmed. Following retroperitoneal dissection (step 3), the pancreatic body and tail were completely mobilized (step 4). Subsequently, Whipple procedure was performed with lymphadenectomy around the right side of the SMA (step 5). Finally, hepaticojejunostomy and gastrojejunostomy were performed (step 6). Using SMA-first approach, en bloc resection with adequate lymphadenectomy around the SMA and retroperitoneal dissection was performed.</p><p><strong>Conclusion: </strong>The present study presents surgical techniques of TP using the SMA-first approach for PC. This unique approach may be useful to perform TP for PC to obtain negative resection margins.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"155-159"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Routine Endoscopic Evaluation of Colorectal Anastomoses for Early Detection of Anastomotic Leakage (REAL Study): Protocol for a Multicenter Prospective Study. 常规内镜评估结直肠吻合器早期发现吻合口漏(REAL研究):一项多中心前瞻性研究方案。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-05-20 DOI: 10.1159/000546041
David J Nijssen, Wytze Laméris, Quentin Denost, Antonino Spinelli, Eloy Espín-Basany, James Kinross, Jurriaan Tuynman, Roel Hompes

Introduction: Early detection and timely treatment of anastomotic leakage (AL) following rectal surgery are crucial for improving outcomes. However, no standardized early detection pathway exists. This study evaluates a multicenter clinical care pathway integrating bedside endoscopy to reduce time to diagnose AL.

Methods: This international, multicenter, prospective observational study evaluates early endoscopic inspection for AL detection. Endoscopic assessments are performed at the bedside using a point-of-care digital rectoscope. Eligible patients include those undergoing colorectal resection for cancer with a colorectal or coloanal anastomosis within 15 cm of the anorectal junction. The clinical pathway includes bedside endoscopic inspection 3-6 days post-surgery, C-reactive protein-guided CT scans with rectal contrast, and follow-up endoscopy at 2-3 weeks. The primary outcome is time to AL diagnosis. Secondary outcomes include diagnostic accuracy, patient-reported comfort (Modified Gloucester Scale), stoma rate, anastomosis healing at 1 year, and cost-effectiveness. A propensity score-matched historical cohort will be used for comparison. Based on previous reports, we hypothesize this pathway will reduce the median diagnosis time from 15 to 5 days. With 95% confidence and 80% power, 130 patients are needed, with 153 total to account for a 15% maximum dropout rate.

Conclusion: The REAL study is designed to evaluate whether a clinical pathway incorporating routine endoscopic assessment of colorectal anastomoses reduces time to diagnosis of AL and initiation of treatment.

前言:直肠手术后吻合口瘘的早期发现和及时治疗对改善预后至关重要。然而,目前尚无标准化的早期检测途径。本研究评估了一种整合床边内窥镜的多中心临床护理途径,以减少诊断AL的时间。方法:这项国际、多中心、前瞻性观察性研究评估了早期内窥镜检查对AL检测的影响。内窥镜评估在床边使用即时数字直肠镜进行。符合条件的患者包括直肠癌行结直肠切除术且结直肠或结直肠吻合术在肛肠结15厘米内的患者。临床路径包括术后3-6天床边内镜检查,c反应蛋白引导CT扫描直肠造影,2-3周随访内镜检查。主要结果是AL诊断的时间。次要结局包括诊断准确性、患者报告的舒适度(改良格洛斯特量表)、造口率、一年内吻合愈合和成本-效果。将使用倾向评分匹配的历史队列进行比较。根据之前的报道,我们假设这种途径将把中位诊断时间从15天减少到5天。在95%的置信度和80%的有效性下,需要130名患者,总共153名患者才能达到15%的最大辍学率。结论:REAL研究旨在评估纳入常规内镜下结肠吻合器评估的临床途径是否缩短了AL的诊断和开始治疗的时间。
{"title":"Routine Endoscopic Evaluation of Colorectal Anastomoses for Early Detection of Anastomotic Leakage (REAL Study): Protocol for a Multicenter Prospective Study.","authors":"David J Nijssen, Wytze Laméris, Quentin Denost, Antonino Spinelli, Eloy Espín-Basany, James Kinross, Jurriaan Tuynman, Roel Hompes","doi":"10.1159/000546041","DOIUrl":"10.1159/000546041","url":null,"abstract":"<p><strong>Introduction: </strong>Early detection and timely treatment of anastomotic leakage (AL) following rectal surgery are crucial for improving outcomes. However, no standardized early detection pathway exists. This study evaluates a multicenter clinical care pathway integrating bedside endoscopy to reduce time to diagnose AL.</p><p><strong>Methods: </strong>This international, multicenter, prospective observational study evaluates early endoscopic inspection for AL detection. Endoscopic assessments are performed at the bedside using a point-of-care digital rectoscope. Eligible patients include those undergoing colorectal resection for cancer with a colorectal or coloanal anastomosis within 15 cm of the anorectal junction. The clinical pathway includes bedside endoscopic inspection 3-6 days post-surgery, C-reactive protein-guided CT scans with rectal contrast, and follow-up endoscopy at 2-3 weeks. The primary outcome is time to AL diagnosis. Secondary outcomes include diagnostic accuracy, patient-reported comfort (Modified Gloucester Scale), stoma rate, anastomosis healing at 1 year, and cost-effectiveness. A propensity score-matched historical cohort will be used for comparison. Based on previous reports, we hypothesize this pathway will reduce the median diagnosis time from 15 to 5 days. With 95% confidence and 80% power, 130 patients are needed, with 153 total to account for a 15% maximum dropout rate.</p><p><strong>Conclusion: </strong>The REAL study is designed to evaluate whether a clinical pathway incorporating routine endoscopic assessment of colorectal anastomoses reduces time to diagnosis of AL and initiation of treatment.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"185-191"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144110220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure. 预防和治疗肝切除术后肝衰竭的药物管理。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-10-17 DOI: 10.1159/000548937
Arja Gerritsen, Marieke T de Boer, Carlijn I Buis, Hans Blokzijl, Marije Smit, Jan-Willem H L Boldingh, Vincent E de Meijer

Background: Posthepatectomy liver failure (PHLF) remains a leading cause of morbidity and mortality following major liver resection. Despite advances in surgical techniques and perioperative care, treatment options for PHLF are limited. Pharmacological interventions targeting ischemia-reperfusion injury and portal flow modulation have gained interest as potential therapeutic strategies.

Summary: This review provides a clinically applicable overview of the current evidence on pharmacological management of PHLF. Perioperative glucocorticoids may reduce inflammatory complications and lower PHLF incidence, though patient selection is crucial. N-acetylcysteine demonstrates antioxidant effects in experimental models and omega-3 fatty acids reduce inflammation, but both lack clinical efficacy. Somatostatin and terlipressin, which modulate portal hemodynamics, have shown promise in preclinical and early-phase clinical studies; however, randomized trials have yet to confirm their benefit in reducing PHLF. Nonselective β-blockers impair liver regeneration in preclinical models and are not recommended posthepatectomy. Early postoperative heparin administration and hyperinsulinemic-normoglycemic strategies have been associated with reduced PHLF but require further validation.

Key messages: While perioperative glucocorticoids may reduce PHLF risk in selected patients, other pharmacological agents show theoretical or preliminary promise, but cannot be routinely recommended based on current evidence. Prospective clinical trials are needed to establish effective pharmacological strategies for the prevention and treatment of PHLF.

肝切除术后肝功能衰竭(PHLF)仍然是主要肝切除术后发病和死亡的主要原因。尽管手术技术和围手术期护理有了进步,但原发性淋巴细胞白血病的治疗选择仍然有限。针对缺血再灌注损伤和门静脉血流调节的药物干预作为潜在的治疗策略已引起人们的兴趣。本文综述了目前PHLF药物治疗的临床应用证据。围手术期使用糖皮质激素可减少炎症并发症,降低PHLF发病率,但患者的选择至关重要。n -乙酰半胱氨酸在实验模型中具有抗氧化作用,omega-3脂肪酸具有减轻炎症的作用,但均缺乏临床疗效。调节门静脉血流动力学的生长抑素和特利加压素在临床前和早期临床研究中显示出前景;然而,随机试验尚未证实它们在降低PHLF方面的益处。在临床前模型中,非选择性β受体阻滞剂损害肝脏再生,不建议在肝切除术后使用。术后早期给予肝素和高胰岛素-正常血糖策略与降低PHLF相关,但需要进一步验证。虽然围手术期糖皮质激素可以降低特定患者的PHLF风险,但其他药理学药物显示出理论或初步的希望,但根据目前的证据不能常规推荐。需要前瞻性临床试验来建立有效的预防和治疗PHLF的药理学策略。
{"title":"Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure.","authors":"Arja Gerritsen, Marieke T de Boer, Carlijn I Buis, Hans Blokzijl, Marije Smit, Jan-Willem H L Boldingh, Vincent E de Meijer","doi":"10.1159/000548937","DOIUrl":"10.1159/000548937","url":null,"abstract":"<p><strong>Background: </strong>Posthepatectomy liver failure (PHLF) remains a leading cause of morbidity and mortality following major liver resection. Despite advances in surgical techniques and perioperative care, treatment options for PHLF are limited. Pharmacological interventions targeting ischemia-reperfusion injury and portal flow modulation have gained interest as potential therapeutic strategies.</p><p><strong>Summary: </strong>This review provides a clinically applicable overview of the current evidence on pharmacological management of PHLF. Perioperative glucocorticoids may reduce inflammatory complications and lower PHLF incidence, though patient selection is crucial. N-acetylcysteine demonstrates antioxidant effects in experimental models and omega-3 fatty acids reduce inflammation, but both lack clinical efficacy. Somatostatin and terlipressin, which modulate portal hemodynamics, have shown promise in preclinical and early-phase clinical studies; however, randomized trials have yet to confirm their benefit in reducing PHLF. Nonselective β-blockers impair liver regeneration in preclinical models and are not recommended posthepatectomy. Early postoperative heparin administration and hyperinsulinemic-normoglycemic strategies have been associated with reduced PHLF but require further validation.</p><p><strong>Key messages: </strong>While perioperative glucocorticoids may reduce PHLF risk in selected patients, other pharmacological agents show theoretical or preliminary promise, but cannot be routinely recommended based on current evidence. Prospective clinical trials are needed to establish effective pharmacological strategies for the prevention and treatment of PHLF.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"301-311"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Factors Influencing Surgical Technique in Hiatal Hernia Repair: In Search for Surgeons' Hidden Algorithm. 影响裂孔疝修补手术技术的患者因素:寻找外科医生的隐算法。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-08 DOI: 10.1159/000545340
Berdel Akmaz, Amber Hameleers, Sander M J van Kuijk, Jan Willem M Greve, Roy F A Vliegen, Evert-Jan G Boerma, Berry Meesters, Jan H M B Stoot

Introduction: Laparoscopic fundoplication is the current standard for HH repair. HH repair can be reinforced with additional anterior sutures, vertical mesh strips (VMS), or mesh placement. We analyzed the influence of patient factors on the surgical technique for laparoscopic repair in a teaching hospital.

Methods: Between 2012 and 2019, all patients who underwent repair of HH were assessed in this retrospective cohort study. HH was measured on CT scans and baseline patient characteristics and surgical details were collected.

Results: In total, 307 patients were included. A total of 208 patients underwent a Toupet fundoplication and 97 patients underwent a Nissen fundoplication. Reinforcements consisted of anterior sutures in 132 patients, VMS in 89 patients, and mesh in 17 patients. The use of anterior sutures was significantly associated with female gender, higher type of HH, and higher age. The use of VMS during surgery was significantly associated with higher type of HH, higher age, and larger transverse diameter of the HH. The use of mesh during surgery was significantly associated with higher type of HH and larger transverse diameter of the HH.

Conclusion: In this retrospective study, the reinforcement techniques used during surgery were significantly associated with patient factors such as gender, body length and weight, type of HH, and transverse diameter. An unexpected patient-associated factor was age.

腹腔镜下扩底术是目前HH修复的标准。HH修复可以通过额外的前缝、垂直网条(VMS)或网片放置来加强。分析了某教学医院腹腔镜修补术中患者因素对手术技术的影响。方法:在2012-2019年期间,对所有接受HH修复的患者进行回顾性队列研究。通过CT扫描测量HH,并收集基线患者特征和手术细节。结果:共纳入307例患者。208例患者接受了Toupet底复制,97例患者接受了Nissen底复制。132例采用前路缝合,89例采用VMS, 17例采用补片。前路缝合的使用与女性、高HH类型和高年龄显著相关。手术中使用VMS与高HH类型、高年龄和大HH横径显著相关。手术中补片的使用与高HH类型和大HH横向直径显著相关。结论:在这项回顾性研究中,手术中使用的加固技术与患者的性别、体长和体重、HH类型和横径等因素显著相关。一个意想不到的患者相关因素是年龄。
{"title":"Patient Factors Influencing Surgical Technique in Hiatal Hernia Repair: In Search for Surgeons' Hidden Algorithm.","authors":"Berdel Akmaz, Amber Hameleers, Sander M J van Kuijk, Jan Willem M Greve, Roy F A Vliegen, Evert-Jan G Boerma, Berry Meesters, Jan H M B Stoot","doi":"10.1159/000545340","DOIUrl":"10.1159/000545340","url":null,"abstract":"<p><strong>Introduction: </strong>Laparoscopic fundoplication is the current standard for HH repair. HH repair can be reinforced with additional anterior sutures, vertical mesh strips (VMS), or mesh placement. We analyzed the influence of patient factors on the surgical technique for laparoscopic repair in a teaching hospital.</p><p><strong>Methods: </strong>Between 2012 and 2019, all patients who underwent repair of HH were assessed in this retrospective cohort study. HH was measured on CT scans and baseline patient characteristics and surgical details were collected.</p><p><strong>Results: </strong>In total, 307 patients were included. A total of 208 patients underwent a Toupet fundoplication and 97 patients underwent a Nissen fundoplication. Reinforcements consisted of anterior sutures in 132 patients, VMS in 89 patients, and mesh in 17 patients. The use of anterior sutures was significantly associated with female gender, higher type of HH, and higher age. The use of VMS during surgery was significantly associated with higher type of HH, higher age, and larger transverse diameter of the HH. The use of mesh during surgery was significantly associated with higher type of HH and larger transverse diameter of the HH.</p><p><strong>Conclusion: </strong>In this retrospective study, the reinforcement techniques used during surgery were significantly associated with patient factors such as gender, body length and weight, type of HH, and transverse diameter. An unexpected patient-associated factor was age.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"127-135"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empiric Antimicrobial Treatment of Anastomotic Leakage after Esophageal Resection: The Most Commonly Used Antimicrobial Regimens in the Netherlands and an Antimicrobial Treatment Recommendation Based on a Single-Center Population. 食管切除术后吻合口瘘的经验性抗菌治疗:荷兰最常用的抗菌方案和基于单中心人群的抗菌治疗推荐。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-03-05 DOI: 10.1159/000545046
Nicole Chatain Lorza, Esther M van Wezel, M H Edwina Doting, Jasper B van Praagh, Jan Willem Haveman

Introduction: The development of anastomotic leakage (AL) after esophagectomy is a severe complication, often leading to mediastinitis and systemic infections. Effective empiric antimicrobial therapy is crucial, but there is no consensus on the optimal regimen. This study aimed to document antimicrobial regimens used in the Netherlands and to evaluate culture results from AL after esophagectomy at our center.

Methods: An online questionnaire about the preferred antimicrobial treatment of AL after esophagectomy was sent to all upper gastrointestinal surgeons in the Netherlands. In addition, drain culture results from patients with AL after esophagectomy in our center were retrospectively analyzed.

Results: From 76 responses, 28 were included, representing 13 of the 15 esophagectomy-performing centers in the Netherlands. For treating AL after esophagectomy, respondents typically choose broad-spectrum regimens covering Gram-negative, Gram-positive, and anaerobic bacteria. The cultures of 57 patients were analyzed. Overall, 61% had positive cultures for yeast, 61% of patients for Enterobacterales, and 16% for Pseudomonas and other non-fermenters.

Conclusion: Based on the studied cultures, empiric antibiotics should cover Gram-positive, Gram-negative, anaerobe bacteria and Pseudomonas. We recommend the use of empiric amoxicillin/clavulanic acid with tobramycin for patients with AL after esophagectomy, which is now protocol in our center. The addition of antifungals remains debatable. Given the high incidence of yeast-positive cultures in the studied cohort, we recommend the addition of an echinocandin in clinically unstable patients.

食管切除术后发生吻合口漏是一种严重的并发症,常导致纵隔炎和全身性感染。有效的经验性抗菌药物治疗是至关重要的,但在最佳治疗方案上尚无共识。本研究旨在记录荷兰使用的抗菌方案,并评估我们中心食管切除术后AL的培养结果。方法:向荷兰所有上消化道外科医生发送一份关于食管切除术后AL首选抗菌药物治疗的在线问卷。此外,我们对本中心食管切除术后AL患者的引流培养结果进行了回顾性分析。结果:从76个应答中,包括28个,代表荷兰15个食管切除术中心中的13个。对于食管切除术后AL的治疗,受访者通常选择广谱方案,包括革兰氏阴性、革兰氏阳性和厌氧菌。分析了57例患者的培养物。61%的患者酵母菌培养阳性,61%的患者肠杆菌培养阳性,16%的患者假单胞菌和其他非发酵菌培养阳性。结论:根据所研究的培养物,经验抗生素应包括革兰氏阳性菌、革兰氏阴性菌、厌氧菌和假单胞菌。我们推荐阿莫西林/克拉维酸联合妥布霉素治疗食管切除术后AL患者,这是我们中心目前的方案。添加抗真菌药物仍有争议。鉴于研究队列中酵母阳性培养的高发生率,我们建议在临床不稳定的患者中添加棘白菌素。
{"title":"Empiric Antimicrobial Treatment of Anastomotic Leakage after Esophageal Resection: The Most Commonly Used Antimicrobial Regimens in the Netherlands and an Antimicrobial Treatment Recommendation Based on a Single-Center Population.","authors":"Nicole Chatain Lorza, Esther M van Wezel, M H Edwina Doting, Jasper B van Praagh, Jan Willem Haveman","doi":"10.1159/000545046","DOIUrl":"10.1159/000545046","url":null,"abstract":"<p><strong>Introduction: </strong>The development of anastomotic leakage (AL) after esophagectomy is a severe complication, often leading to mediastinitis and systemic infections. Effective empiric antimicrobial therapy is crucial, but there is no consensus on the optimal regimen. This study aimed to document antimicrobial regimens used in the Netherlands and to evaluate culture results from AL after esophagectomy at our center.</p><p><strong>Methods: </strong>An online questionnaire about the preferred antimicrobial treatment of AL after esophagectomy was sent to all upper gastrointestinal surgeons in the Netherlands. In addition, drain culture results from patients with AL after esophagectomy in our center were retrospectively analyzed.</p><p><strong>Results: </strong>From 76 responses, 28 were included, representing 13 of the 15 esophagectomy-performing centers in the Netherlands. For treating AL after esophagectomy, respondents typically choose broad-spectrum regimens covering Gram-negative, Gram-positive, and anaerobic bacteria. The cultures of 57 patients were analyzed. Overall, 61% had positive cultures for yeast, 61% of patients for Enterobacterales, and 16% for Pseudomonas and other non-fermenters.</p><p><strong>Conclusion: </strong>Based on the studied cultures, empiric antibiotics should cover Gram-positive, Gram-negative, anaerobe bacteria and Pseudomonas. We recommend the use of empiric amoxicillin/clavulanic acid with tobramycin for patients with AL after esophagectomy, which is now protocol in our center. The addition of antifungals remains debatable. Given the high incidence of yeast-positive cultures in the studied cohort, we recommend the addition of an echinocandin in clinically unstable patients.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"68-76"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143566311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1